These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 26423666)
1. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma. Wang P; He Y; Ma X; Sun B; Huang B; Zhu C; Liu Y Med Sci Monit; 2015 Oct; 21():2943-9. PubMed ID: 26423666 [TBL] [Abstract][Full Text] [Related]
2. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods]. Wang X; Zhang J; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma. Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663 [TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma. Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921 [TBL] [Abstract][Full Text] [Related]
5. Down stream involvement of the bile duct in hepatolithiasis. Lu S; Yan L; Rao L; Xia T; Gou J; Zhang S; Lei S Chin Med J (Engl); 2002 Jan; 115(1):62-4. PubMed ID: 11930661 [TBL] [Abstract][Full Text] [Related]
6. Silver-binding nucleolar organizer regions in hepatolithiasis and bile duct cancer. Ker CG Proc Natl Sci Counc Repub China B; 1997 Apr; 21(2):43-8. PubMed ID: 9276966 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483 [TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677 [TBL] [Abstract][Full Text] [Related]
9. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis. Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma. Hirashima K; Iyama K; Baba Y; Honda Y; Sado Y; Ninomiya Y; Watanabe M; Takamori H; Beppu T; Baba H J Surg Oncol; 2013 Mar; 107(4):402-7. PubMed ID: 22927259 [TBL] [Abstract][Full Text] [Related]
11. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma. Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207 [TBL] [Abstract][Full Text] [Related]
12. Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis. Ker CG; Sheen PC; Chien CH; Wu CC Surg Today; 1993; 23(6):496-9. PubMed ID: 8358193 [TBL] [Abstract][Full Text] [Related]
13. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma. Choi HJ; Kim HJ; Choi JH Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358 [TBL] [Abstract][Full Text] [Related]
15. A study of CEA, CA 19-9 and CA 125 in biliary tract diseases. Ker CG; Wu CC; Chen JS; Hou MF; Lee KT; Sheen PC Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Feb; 5(2):107-13. PubMed ID: 2733069 [TBL] [Abstract][Full Text] [Related]
16. [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma]. Kim HJ; Kim JS; Kang CD; Lee SJ; Kim JY; Yeon JE; Park JJ; Shim JJ; Byun KS; Bak YT; Lee CH Korean J Gastroenterol; 2005 Jan; 45(1):52-9. PubMed ID: 15665568 [TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer. Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138 [TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis. Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604 [TBL] [Abstract][Full Text] [Related]
19. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance. Zheng J; Zhu YM Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040 [TBL] [Abstract][Full Text] [Related]
20. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]